MP-424
G060-A9
Phase 3 small_molecule completed
Quick answer
MP-424 for Hepatitis C is a Phase 3 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 2 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Hepatitis C
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed